Clinicopathological characteristics and treatment of carcinosarcoma of the female genital tract

被引:1
作者
Jun Zhu [1 ]
Hao Wen [1 ]
Xiaohua Wu [1 ]
机构
[1] Department of Gynecologic Oncology,Cancer Hospital of Fudan University
关键词
carcinosarcoma; pathology; treatment; prognosis;
D O I
暂无
中图分类号
R737.3 [女性生殖器肿瘤];
学科分类号
100214 ;
摘要
Carcinosarcomas of the female genital tract are highly aggressive and rare tumors,differing from other malignant gynecological tumors in that they contain both malignant carcinomatous and sarcomatous elements. Because carcinosarcomas are rapidly progressive,less sensitive to chemotherapy or radiotherapy,and have a high probability of recurrence,patients with advanced uterine and ovarian carcinosarcomas have poorer survival than those with endometrial or high-grade serous carcinomas. Although the treatment strategies are controversial,a comprehensive management approach is recommended,which involves complete debulking surgery followed by adjuvant chemotherapy and/or radiotherapy. Molecular-targeted therapies are promising for the management and improvement in the overall survival of patients with carcinosarcomas.
引用
收藏
页码:233 / 238
页数:6
相关论文
共 36 条
  • [1] Demographics and Clinical Outcomes of Carcinosarcoma of the Uterus: A Population Based Clinical Outcomes Study From the Surveillance Epidemiology and End Results (SEER) Database (1973-2010)[J] . K. Mahendraraj,I. Moore,R.S. Chamberlain.Journal of Surgical Research . 2014 (2)
  • [2] Carcinosarcoma of the ovary: Natural history, patterns of treatment, and outcome[J] . Erin M. George,Thomas J. Herzog,Alfred I. Neugut,Yu-Shiang Lu,William M. Burke,Sharyn N. Lewin,Dawn L. Hershman,Jason D. Wright.Gynecologic Oncology . 2013
  • [3] HER2/neu as a Potential Target for Immunotherapy in Gynecologic Carcinosarcomas
    Guzzo, Federica
    Bellone, Stefania
    Buza, Natalia
    Hui, Pei
    Carrara, Luisa
    Varughese, Joyce
    Cocco, Emiliano
    Betti, Marta
    Todeschini, Paola
    Gasparrini, Sara
    Schwartz, Peter E.
    Rutherford, Thomas J.
    Angioli, Roberto
    Pecorelli, Sergio
    Santin, Alessandro D.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2012, 31 (03) : 211 - 221
  • [4] The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma
    Tanner, Edward J.
    Leitao, Mario M., Jr.
    Garg, Karuna
    Chi, Dennis S.
    Sonoda, Yukio
    Gardner, Ginger J.
    Barakat, Richard R.
    Jewell, Elizabeth L.
    [J]. GYNECOLOGIC ONCOLOGY, 2011, 123 (03) : 548 - 552
  • [5] Carcinosarcoma of the ovary: A case–control study[J] . J. Alejandro Rauh-Hain,Whitfield B. Growdon,Noah Rodriguez,A.K. Goodman,David M. Boruta,John O. Schorge,Neil S. Horowitz,Marcela G. del Carmen.Gynecologic Oncology . 2011 (3)
  • [6] Can MRI predict the diagnosis of endometrial carcinosarcoma?
    Genever, A. V.
    Abdi, S.
    [J]. CLINICAL RADIOLOGY, 2011, 66 (07) : 621 - 624
  • [7] Primary mixed mullerian tumor of the vagina-A case report with review of the literature
    Ahuja, Arvind
    Safaya, Rajni
    Prakash, Gaurav
    Kumar, Lalit
    Shukla, Nootan Kumar
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2011, 207 (04) : 253 - 255
  • [8] Uterine Carcinosarcoma
    El-Nashar, Sherif A.
    Mariani, Andrea
    [J]. CLINICAL OBSTETRICS AND GYNECOLOGY, 2011, 54 (02) : 292 - 304
  • [9] A Phase II Trial of Paclitaxel and Carboplatin in Women With Advanced or Recurrent Uterine Carcinosarcoma
    Lacour, Robin A.
    Euscher, Elizabeth
    Atkinson, E. Neely
    Sun, Charlotte C.
    Ramirez, Pedro T.
    Coleman, Robert L.
    Brown, Jubilee
    Gano, Jacalyn B.
    Burke, Thomas W.
    Ramondetta, Lois Michelle
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (03) : 517 - 522
  • [10] COX-2 expression in uterine carcinosarcoma
    Menczer, Joseph
    Schreiber, Letizia
    Sukmanov, Oleg
    Kravtsov, Vladimir
    Berger, Esther
    Golan, Abraham
    Levy, Tally
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2010, 89 (01) : 120 - 125